Maartens G - Search Results

1

Lack of association between stavudine exposure and lipoatrophy, dysglycaemia, hyperlactataemia and hypertriglyceridaemia: a prospective cross sectional study.

Sinxadi PZ, van der Walt JS, McIlleron HM, Badri M, Smith PJ, Dave JA, Levitt NS, Maartens G. Sinxadi PZ, et al. Among authors: maartens g. AIDS Res Ther. 2010 Jul 14;7:23. doi: 10.1186/1742-6405-7-23. AIDS Res Ther. 2010. PMID: 20630064 Free PMC article.

2

Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.

Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Badri M, et al. Among authors: maartens g. Int J Tuberc Lung Dis. 2001 Mar;5(3):225-32. Int J Tuberc Lung Dis. 2001. PMID: 11326821

3

Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.

Badri M, Ehrlich R, Wood R, Maartens G. Badri M, et al. Among authors: maartens g. AIDS. 2001 Jun 15;15(9):1143-8. doi: 10.1097/00002030-200106150-00009. AIDS. 2001. PMID: 11416716

4

AIDS in Africa--survival according to AIDS-defining illness.

Post FA, Badri M, Wood R, Maartens G. Post FA, et al. Among authors: maartens g. S Afr Med J. 2001 Jul;91(7):583-6. S Afr Med J. 2001. PMID: 11544975

5

Predictors and prognostic value of oral hairy leukoplakia and oral candidiasis in South African HIV-infected patients.

Badri M, Maartens G, Wood R. Badri M, et al. Among authors: maartens g. SADJ. 2001 Dec;56(12):592-6. SADJ. 2001. PMID: 11887444

6

Tuberculosis should not be considered an AIDS-defining illness in areas with a high tuberculosis prevalence.

Badri M, Ehrlich R, Pulerwitz T, Wood R, Maartens G. Badri M, et al. Among authors: maartens g. Int J Tuberc Lung Dis. 2002 Mar;6(3):231-7. Int J Tuberc Lung Dis. 2002. PMID: 11934141

7

Cost-effectiveness of highly active antiretroviral therapy in South Africa.

Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, Platt RW, Wood R, Beck EJ. Badri M, et al. Among authors: maartens g. PLoS Med. 2006 Jan;3(1):e4. doi: 10.1371/journal.pmed.0030004. Epub 2005 Dec 6. PLoS Med. 2006. PMID: 16318413 Free PMC article.

8

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R. Badri M, et al. Among authors: maartens g. Antivir Ther. 2006;11(1):63-72. Antivir Ther. 2006. PMID: 16518961

9

High prevalence of subtherapeutic plasma concentrations of efavirenz in children.

Ren Y, Nuttall JJ, Egbers C, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM. Ren Y, et al. Among authors: maartens g. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):133-6. doi: 10.1097/QAI.0b013e31805c9d52. J Acquir Immune Defic Syndr. 2007. PMID: 17417100 Clinical Trial.

10

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.

McIlleron H, Meintjes G, Burman WJ, Maartens G. McIlleron H, et al. Among authors: maartens g. J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75. doi: 10.1086/518655. J Infect Dis. 2007. PMID: 17624828 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters